Immunoglobulin G-dependent enhancement of the infection with Coxsackievirus B4 in a murine system

References

• Knowles NJ, Hovi T, Hyypiä T, King AMQ, Lindberg M, Pallansch MA, Palmenberg AC, Simmonds P, Skern T, Stanway G, et al. 2012. Picornaviridae. In Virus Taxonomy: Classification and Nomenclature of Viruses: Ninth Report of the International Committee on Taxonomy of Viruses; King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ, Eds.; Publisher: San Diego, CA, 2012; pp. 855–880.
   Google Scholar
• Jaïdane H, Sauter P, Sane F, Goffard A, Gharbi J, Hober D. Enteroviruses and type 1 diabetes: towards a better understanding of the relationship. Rev Med Virol 2010; 20:265-80; http://dx.doi.org/10.1002/rmv.647
   PubMed Web of Science ®Google Scholar
• Jaïdane H, Sané F, Gharbi J, Aouni M, Romond MB, Hober D. Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models. Diabetes Metab Res Rev 2009; 25:591-603; http://dx.doi.org/10.1002/dmrr.995
   PubMed Web of Science ®Google Scholar
• Hober D, Sauter P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol 2010; 6:279-89; PMID:20351698; http://dx.doi.org/10.1038/nrendo.2010.27
   PubMed Web of Science ®Google Scholar
• Yeung W-CG, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 2011; 342:d35; PMID:21292721; http://dx.doi.org/10.1136/bmj.d35
   PubMed Web of Science ®Google Scholar
• Chehadeh W, Bouzidi A, Alm G, Wattré P, Hober D. Human antibodies isolated from plasma by affinity chromatography increase the coxsackievirus B4-induced synthesis of interferon-alpha by human peripheral blood mononuclear cells in vitro. J Gen Virol 2001; 82:1899-907; PMID:11457996; http://dx.doi.org/10.1099/0022-1317-82-8-1899
   PubMed Web of Science ®Google Scholar
• Hober D, Chehadeh W, Weill J, Hober C, Vantyghem M-C, Gronnier P, Wattré P. Circulating and cell-bound antibodies increase coxsackievirus B4-induced production of IFN-alpha by peripheral blood mononuclear cells from patients with type 1 diabetes. J Gen Virol 2002; 83:2169-76; PMID:12185270; http://dx.doi.org/10.1099/0022-1317-83-9-2169
   PubMed Web of Science ®Google Scholar
• Hober D, Chehadeh W, Bouzidi A, Wattré P. Antibody-dependent enhancement of coxsackievirus B4 infectivity of human peripheral blood mononuclear cells results in increased interferon-alpha synthesis. J Infect Dis 2001; 184:1098-108; PMID:11598831; http://dx.doi.org/10.1086/323801
   PubMed Web of Science ®Google Scholar
• Sauter P, Hober D. Mechanisms and results of the antibody-dependent enhancement of viral infections and role in the pathogenesis of coxsackievirus B-induced diseases. Microbes Infect 2009; 11:443-51; PMID:19399964; http://dx.doi.org/10.1016/j.micinf.2009.01.005
   PubMed Web of Science ®Google Scholar
• Jaïdane H, Gharbi J, Lobert P-E, Lucas B, Hiar R, M'hadheb MB, Brilot F, Geenen V, Aouni M, Hober D. Prolonged viral RNA detection in blood and lymphoid tissues from coxsackievirus B4 E2 orally-inoculated Swiss mice. Microbiol Immunol 2006; 50:971-4; http://dx.doi.org/10.1111/j.1348-0421.2006.tb03874.x
   PubMed Web of Science ®Google Scholar
• Jaïdane H, Gharbi J, Lobert P-E, Caloone D, Lucas B, Sané F, Idziorek T, Romond M-B, Aouni M, Hober D. Infection of primary cultures of murine splenic and thymic cells with coxsackievirus B4. Microbiol Immunol 2008; 52:40-6; http://dx.doi.org/10.1111/j.1348-0421.2008.00002.x
   PubMed Web of Science ®Google Scholar
• Chehadeh W, Lobert P-E, Sauter P, Goffard A, Lucas B, Weill J, Vantyghem M-C, Alm G, Pigny P, Hober D. Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4- and B3-induced synthesis of alpha interferon. J Virol 2005; 79:13882-91; PMID:16254324; http://dx.doi.org/10.1128/JVI.79.22.13882-13891.2005
   PubMed Web of Science ®Google Scholar
• Goffard A, Alidjinou EK, Sané F, Choteau L, Bouquillon C, Caloone D, Lobert PE, Hober D. Antibodies enhance the infection of phorbol-ester-differentiated human monocyte-like cells with coxsackievirus B4. Microbes Infect 2013; 15:18-27; PMID:23108316; http://dx.doi.org/10.1016/j.micinf.2012.10.005
   PubMed Web of Science ®Google Scholar
• Sauter P, Lobert P-E, Lucas B, Varela-Calvino R, Alm G, Wattre P, Hober D. Role of the capsid protein VP4 in the plasma-dependent enhancement of the Coxsackievirus B4E2-infection of human peripheral blood cells. Virus Res 2007; 125:183-90; PMID:17291618; http://dx.doi.org/10.1016/j.virusres.2007.01.001
   PubMed Web of Science ®Google Scholar
• Beck MA, Chapman NM, McManus BM, Mullican JC, Tracy S. Secondary enterovirus infection in the murine model of mycarditis. Am J Pathol 1990; 156: 669-81.
   Google Scholar
• Yu JZ, Wilson JE, Wood SM, Kandolf R, Klingel K, Yang D, McManus BM. Secondary heterotypic versus homotypic infection by Coxsackie B group viruses: impact onearly and late histopathological lesions and virus genome prominence. Cardiovasc Pathol 1999; 8:93-102; PMID:10724506; http://dx.doi.org/10.1016/S1054-8807(98)00025-8
   PubMed Web of Science ®Google Scholar
• Girn J, Kavoosi M, Chantler J. Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain. J Gen Virol 2002; 83:351-8; PMID:11807228; http://dx.doi.org/10.1099/0022-1317-83-2-351
   PubMed Web of Science ®Google Scholar
• Kishimoto C, Kurokawa M, Ochiai H. Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis. J Mol Cell Cardiol 2002; 3:1227-38; http://dx.doi.org/10.1006/jmcc.2002.2087
   Google Scholar
• Takada A, Kawaoka Y. Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev Med Virol 2003; 13(6):387-98; PMID:14625886; http://dx.doi.org/10.1002/rmv.405
   PubMed Web of Science ®Google Scholar
• Horwitz MS, Ilic A, Fine C, Rodriguez E, Sarvetnick N.Coxsackievirus-mediated hyperglycemia is enhanced by reinfection and this occurs independent of T cells. Virology 2003; 314(2):510-20; PMID:14554080; http://dx.doi.org/10.1016/S0042-6822(03)00462-8
   PubMed Web of Science ®Google Scholar
• Bopegamage S, Precechtelova J, Marosova L, Stipalova D, Sojka M, Borsanyiova M, Gomolcak P, Berakova K, Galama JM. Outcome of challenge with Coxsackievirus B4 in young mice after maternal infection with thesame virus during gestation. FEMS Immunol Med Microbiol 2012; 64(2):184-90; PMID:22066931; http://dx.doi.org/10.1111/j.1574-695X.2011.00886.x
   PubMedGoogle Scholar
• Zamzami N, Marchetti P, Castedo M, Hirsch T, Susin SA, Masse B, Kroemer G. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett 1996; 384:53-7; PMID:8797802; http://dx.doi.org/10.1016/0014-5793(96)00280-3
   PubMed Web of Science ®Google Scholar
• Jaïdane H, CalooneD, Lobert PE, Sane F, Dardenne O, Naquet P, Gharbi J, Aouni M, Geenen V, Hober D. Persistent infection of thymic epithelial cells with coxsackievirus B4 results in decreased expression of type 2 insulin-like growth factor. J Virol 2012; 86(20):11151-62; http://dx.doi.org/10.1128/JVI.00726-12
   PubMed Web of Science ®Google Scholar